Improving COVID-19 vaccine acceptance in correctional facilities
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
This study is trying to find better ways to encourage people in jails and prisons, as well as the staff, to get vaccinated against COVID-19 and the flu.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 37122 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (Schwenksville, Pennsylvania) |
| Trial ID | NCT05796505 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance vaccine uptake for COVID-19 and influenza among incarcerated individuals and correctional staff in Pennsylvania. It employs a community-engaged research approach to identify effective strategies for increasing vaccine acceptance. The study will utilize rapid cycle, cluster randomized trials to evaluate the effectiveness of these interventions. The findings are expected to provide a scalable evidence base for improving vaccination rates in correctional settings and potentially other affected populations.
Who should consider this trial
Good fit: Ideal candidates for this study are all incarcerated individuals within the Pennsylvania Department of Corrections.
Not a fit: Patients with severe physical or mental illnesses who are housed in special medical units will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce COVID-19 morbidity and mortality among incarcerated individuals and correctional staff.
How similar studies have performed: This approach is innovative and has not been extensively tested in correctional settings, making it a novel initiative.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All incarcerated people in the Pennsylvania DOC are included in the study population for these low risk interventions. In this each individual intervention, inclusion criteria will be based on where incarcerated people are housed and therefore what intervention they will be exposed to. Exclusion Criteria: * Exclusion criteria will likely include severe physical or mental illness as these individuals are often incarcerated in special units which will not be included in the study (i.e. medical units).
Where this trial is running
Schwenksville, Pennsylvania
- Pennsylvannia Department of Corrections — Schwenksville, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Lisa B Puglisi, MD — Yale University
- Study coordinator: Lisa B Puglisi, MD
- Email: Lisa.puglisi@yale.edu
- Phone: 475-306-1023
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.